Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466622
Status:
COMPLETED
Last Update Posted:
2016-07-20
First Post:
2007-04-26
Brief Title:
Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Uterine Artery Blood Flow in Pregnant Women With Polycystic Ovary SyndromePCOSTreated With Metformin - a Substudy to The PregMet Study
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FlowMet
Brief Summary:
FlowMet study is a sub-study of the PregMet study registered in 2005
The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregnant PCOS women The participants will be examined with ultrasound Doppler in gestational week 10-13
1 before and 3h after the first tablet intake of metforminplacebo
2 and 10-14 days after inclusion in the trial
3 blood flow in the umbilical artery and fetal cerebral artery in gestational week 24
The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregnant PCOS women The participants will be examined with ultrasound Doppler in gestational week 10-13
1 before and 3h after the first tablet intake of metforminplacebo
2 and 10-14 days after inclusion in the trial
3 blood flow in the umbilical artery and fetal cerebral artery in gestational week 24
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None